CORAL GABLES, Fla. (AP) — CORAL GABLES, Fla. (AP) — Catalyst Pharmaceutical Partners Inc. (CPRX) on Wednesday reported a loss of $30.8 million in its third quarter.
The Coral Gables, Florida-based company said it had a loss of 29 cents per share. Losses, adjusted for one-time gains and costs, came to 24 cents per share.
The specialty drug company posted revenue of $102.7 million in the period, surpassing Street forecasts. Five analysts surveyed by Zacks expected $100.2 million.
Catalyst expects full-year revenue in the range of $390 million to $395 million.